Engineers Gate Manager LP T2 Biosystems, Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.86 - $1.21 $16,683 - $23,472	-19,399 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.69 $20,018 - $32,530	-19,249 Reduced 49.81%	19,399 $23,000
Q1 2021 May 17, 2021	BUY	$1.32 - $3.79 $51,015 - $146,475	38,648 New	38,648 $63,000
Q4 2020 Feb 16, 2021	SELL	$1.06 - $1.51 $37,131 - $52,895	-35,030 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.15 - $2.1 $26,724 - $48,801	-23,239 Reduced 39.88%	35,030 $48,000
Q2 2020 Aug 17, 2020	BUY	$0.48 - $1.67 $27,969 - $97,309	58,269 New	58,269 $74,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $5.99M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.